Editors' Picks
High-Quality Glaxo Could Still Have Something Left by Stephen Simpson
Post-Tysabri, Will Elan Waste The Windfall? by Stephen Simpson
Bahrain
Invacare CEO discusses Q4 2012 Results - Earnings Call Transcript
China
What To Expect From China ETFs Post-Lunar New Year by Benzinga
Sina's $68 Valuation: Key Drivers And Potential Risks by Trefis
6 High-Growth BRIC Small And Mid Caps With Bullish Short Trends by Kapitall
China Slams Qihoo 360 Technologies For Faking Microsoft Patch by Maani Value Guru
Short Interest Is Decreasing In These Chinese Stocks by Justin Giles
Ireland
Post-Tysabri, Will Elan Waste The Windfall? by Stephen Simpson
Italy
Japan
Currency Wars Over Before They Begin? by Tim Duy
ETF Showdown: Settling The Japan Debate by Benzinga
It's Time to Buy These Two International Markets, Stat by Lou Basenese
Spain
Investment Rationale For Banco Santander by Gasebu Private Investor
Switzerland
Revising Credit Suisse Estimate To $32 On Outlook, Despite Mixed Results by Trefis
United Kingdom
High-Quality Glaxo Could Still Have Something Left by Stephen Simpson
Canada
A Flurry Of Competition Will Hamper BlackBerry's Sales by Vlad Deshkovich
Lone Pine Resources: Time Is On My Side by Credit Master
BlackBerry Success: More Than Meets The Eye by Mark Spiteri
Oncolytics Biotech Shares Soar On Reolysin Trial Success by Maani Value Guru
Why are you receiving this? You subscribed to Global Investing at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No comments:
Post a Comment